Alfonso Pompella

Alfonso Pompella

Auto-generated profile, based on publicly available information

Alfonso Pompella

Department of Experimental Pathology, University of Pisa, Italy

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2003 in Biochemical Pharmacology
Verified
Journal Article
Closed access
APAlfonso Pompella
Alfonso Pompella
AVAthanase Visvikis
Athanase Visvikis
APAldo Paolicchi
Aldo Paolicchi
VTVincenzo De Tata
Vincenzo De Tata
ACAlessandro F. Casini
Alessandro F. Casini


1 January 2004 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
APAlfonso Pompella
Alfonso Pompella
MEMichele Emdin
Michele Emdin
CPClaudio PASSINO
Claudio PASSINO
APAldo Paolicchi
Aldo Paolicchi
Since early after the introduction of serum γ-glutamyltransferase (GGT) in clinical practice as a reliable and widely employed laboratory test, epidemiological and prospective studies have repeatedly shown that this activity possesses a prognostic value for morbidity and mortality. The association is independent of possibly concomitant conditions of liver disease, and notably, a significant independent correlation of serum GGT exists with the occurrence of cardiovascular diseases (myocardial infarction, stroke). Experimental work has documented that active GGT is present in atherosclerotic plaques of coronary as well as in cerebral arteries. These findings, and the recently recognized functions of GGT in the generation of reactive oxygen species, indicate that serum GGT represents a true marker of cardiovascular diseases and underlying atherosclerosis. Further insights into potential therapeutic interest will probably be derived from studies investigating the origin of GGT activity in plaque tissue.

30 September 2008 in Clinica Chimica Acta
Verified
Journal Article
Closed access
MFMaria Franzini
Maria Franzini
VOVirginia Ottaviano
Virginia Ottaviano
VFVanna Fierabracci
Vanna Fierabracci
Emilia BramantiEmilia Bramanti
Emilia Bramanti
LZLuc Zyw
Luc Zyw
APAldo Paolicchi
Aldo Paolicchi

28 October 2009 in Biomarkers
Verified
Journal Article
Closed access
PDF file
MFMaria Franzini
Maria Franzini
ACAlessandro Corti
Alessandro Corti
IFIrene Fornaciari
Irene Fornaciari
MBMichela Balderi
Michela Balderi
FTFrancesca Torracca
Francesca Torracca
APAldo Paolicchi
Aldo Paolicchi
Serum γ-glutamyltransferase (GGT) is thought to derive from the liver, but its values predict morbidity and mortality for several diseases, such as cardiac infarction, stroke, diabetes, renal failure and cancer. We assessed total GGT and its fractions in the culture supernatants of human cell lines (melanoma, prostate cancer, bronchial epithelium) by gel filtration chromatography. We also compared the GGT elution profile in plasma and the corresponding very-low-density lipoprotein (VLDL) fraction. All the cell lines tested released soluble GGT whose activity increased in parallel with the cell growth. Released GGT presented a molecular weight of 2000 kDa, identical to the b-GGT fraction of human plasma and corresponding to that of VLDL. But ultracentrifugation studies showed that b-GGT had a higher density than VLDL. The b-GGT present in human plasma can be produced by tissues other than the liver, thus explaining the increase of serum GGT observed in diseases of other organs.

1 July 2003 in Tumori Journal
Verified
Journal Article
Open access
SDSilvia Dominici
Silvia Dominici
AVAthanase Visvikis
Athanase Visvikis
LPLisa Pieri
Lisa Pieri
APAldo Paolicchi
Aldo Paolicchi
MVMarta A Valentini
Marta A Valentini
APAlfonso Pompella
Alfonso Pompella
Aims and background: The transcription factor NF-κB is implicated in the expression of genes involved in cell proliferation, apoptosis and metastasis. In melanoma, high constitutive levels of NF-κB activation are usually observed. NF-κB is regulated by oxidation/reduction (redox) processes, and the occurrence of constitutive oxidative stress in melanoma cells has been documented. Recent studies of our laboratories showed that the membrane-bound gamma-glutamyl transferase (GGT) enzyme activity – expressed by a number of malignancies, including melanoma – can act as a basal source of superoxide, hydrogen peroxide and other prooxidants. Methods: In the present study we utilized the 2/60 clone of Me665/2 human metastatic melanoma, which displays high levels of GGT activity, in order to verify if the presence of this enzyme - through the promotion of redox processes - may influence the activation status of NF-κB. The latter was evaluated by determining the nuclear translocation of the p65 subunit (by immunoblot), the DNA binding of NF-kB (by elec-trophoretic mobility shift assay) and its transcriptional activity (by gene transactivation studies). Results: Me665/2/60 cells displayed a basal production of hydrogen peroxide. Stimulation of GGT activity by its substrates glutathione and glycyl-glycine caused additional production of hydrogen peroxide, up to levels approx. double the basal levels. Nuclear translocation of the NF-κB p65 subunit, DNA-binding and gene transactivation were thus investigated in Me665/2/60 cells whose GGT activity was modulated by means of substrates or inhibitors. Stimulation of GGT activity resulted in increased nuclear translocation of p65, while on the other hand NF-κB DNA binding and gene transactivation were paradoxically decreased. NF-κB DNA binding could be restored by treating cell lysates with the thiol-re-ducing agent dithiothreitol (DTT). Treatment of cells with exogenous hydrogen peroxide did not affect NF-κB activation status. Conclusions: Altogether, the data obtained indicate that GGT activity may impair the redox status of thiols that is critical for NF-κB DNA binding and gene transactivation, through the production of prooxidant species allegedly distinct from hydrogen peroxide. GGT activity therefore appears to be an additional factor in modulation of NF-κB transcriptional activity in melanoma, capable of hindering NF-κB DNA binding even in conditions where continuous oxidative stress would favor NF-κB nuclear translocation.